Trump tariffs could raise drug costs, worsen shortages

President Trump’s Tariffs Could Worsen US Drug Shortages, Raise Healthcare Costs

President Donald Trump’s steep tariffs on Canada, Mexico, and China could worsen existing drug shortages in the US, raise healthcare costs for patients, and threaten cash-strapped generic drugmakers, some drug trade groups warn.

Impact on Generic Drugs

The US relies heavily on other countries for pharmaceutical products, especially for generic drugs, which make up 90% of Americans’ prescriptions. Those medications are often manufactured overseas at lower costs. The tariffs could increase already problematic drug shortages by forcing generic manufacturers out of the market due to low profit margins.

Warnings from Drug Trade Groups

John Murphy, CEO of the Association for Accessible Medicines, which represents generic pharmaceutical companies, urged the Trump administration to exempt generic products from tariffs. He stated that generic manufacturers simply cannot absorb new costs and that the overall value of all generic sales in the US has decreased by $6.4 billion in five years despite growth in volume and new generic drug launches.

Healthcare Distribution Alliance’s Concerns

The Healthcare Distribution Alliance, which represents 40 drug distributors, has also called for the Trump administration to reconsider including pharmaceutical products in tariffs. The group warned that tariffs will strain the pharmaceutical supply chain and could adversely affect American patients, whether that is through increased medical product costs or manufacturers leaving the market.

Estimated Impact

An estimate from The Budget Lab at Yale University said long-term prices of pharmaceutical products in the US will be 1.1% higher after shifts in the supply chain.

Impact on Medical Devices

The US also relies on overseas manufacturing for medical devices, with many key components and finished products being sourced from countries such as China, Mexico, and India. Tariffs on these countries could increase the costs of medical products and lead to shortages of critical medical technologies, higher prices for patients and payers, and less investment in research and development.

Conclusion

The tariffs imposed by President Trump could have far-reaching consequences for the pharmaceutical and medical device industries in the US. The increased costs and potential shortages of crucial medicines and medical technologies could lead to higher healthcare costs for patients and potentially worsen existing drug shortages.

Frequently Asked Questions

Q: What is the impact of tariffs on generic drugs?
A: The tariffs could increase already problematic drug shortages by forcing generic manufacturers out of the market due to low profit margins.

Q: How do tariffs affect the pharmaceutical supply chain?
A: Tariffs will strain the pharmaceutical supply chain and could adversely affect American patients, whether that is through increased medical product costs or manufacturers leaving the market.

Q: What is the estimated impact of tariffs on pharmaceutical prices?
A: Long-term prices of pharmaceutical products in the US will be 1.1% higher after shifts in the supply chain.

Q: How do tariffs affect medical devices?
A: Tariffs could increase the costs of medical products and lead to shortages of critical medical technologies, higher prices for patients and payers, and less investment in research and development.